Literature DB >> 18416998

Aortic occlusion for cerebral ischemia: from theory to practice.

David S Liebeskind1.   

Abstract

Ischemic stroke is a devastating disorder with limited treatment options. Arterial recanalization with thrombolysis or mechanical thrombectomy may be used to restore perfusion in only a subset of cases. Collateral therapeutic strategies such as partial aortic occlusion attempt to reverse ischemia, the principal detrimental element in stroke pathophysiology. This article considers the theoretic basis of aortic occlusion as a therapeutic strategy for cerebral ischemia, procedural details employing the NeuroFlo (CoAxia, Maple Grove, MN) device, ongoing and prior clinical studies, and potential practice implications in the future. The hemodynamic mechanisms associated with flow redistribution due to aortic occlusion and impact on the dynamic role of collateral perfusion in the ischemic brain are considered. Targeting ischemia rather than clot disruption or consideration of venous hemodynamics and flow redistribution may initiate a radical transformation in stroke care. Ultimately, demonstration of a rational mechanism that averts ischemia will be essential.

Entities:  

Mesh:

Year:  2008        PMID: 18416998     DOI: 10.1007/s11886-008-0007-3

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  36 in total

1.  Approval of the MERCI clot retriever: a critical view.

Authors:  Kyra J Becker; Thomas G Brott
Journal:  Stroke       Date:  2005-01-13       Impact factor: 7.914

2.  Alterations in intracranial volume following cross-clamping of the descending thoracic aorta in pigs--an experimental study using MRI.

Authors:  T Strømholm; O D Saether; P Aadahl; G Nilsen; J Kvaerness; H O Myhre
Journal:  Eur J Vasc Endovasc Surg       Date:  1995-07       Impact factor: 7.069

3.  Blood volume redistribution during cross-clamping of the descending aorta.

Authors:  S Gelman; M B Khazaeli; R Orr; T Henderson
Journal:  Anesth Analg       Date:  1994-02       Impact factor: 5.108

Review 4.  Intra-aortic balloon counterpulsation augments cerebral blood flow in the patient with cerebral vasospasm: a xenon-enhanced computed tomography study.

Authors:  E S Nussbaum; L A Sebring; W F Ganz; M T Madison
Journal:  Neurosurgery       Date:  1998-01       Impact factor: 4.654

5.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

6.  Intra-aortic balloon counterpulsation augments cerebral blood flow in a canine model of subarachnoid hemorrhage-induced cerebral vasospasm.

Authors:  E S Nussbaum; R C Heros; E E Solien; M T Madison; L A Sebring; R E Latchaw
Journal:  Neurosurgery       Date:  1995-04       Impact factor: 4.654

7.  Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1).

Authors:  Yair Lampl; Justin A Zivin; Marc Fisher; Robert Lew; Lennart Welin; Bjorn Dahlof; Peter Borenstein; Bjorn Andersson; Julio Perez; Cesar Caparo; Sanja Ilic; Uri Oron
Journal:  Stroke       Date:  2007-04-26       Impact factor: 7.914

8.  Cardiac effects of splanchnic and non-splanchnic blood volume redistribution during aortic occlusions in dogs.

Authors:  O Stokland; M Molaug; J Thorvaldson; A Ilebekk; F Kiil
Journal:  Acta Physiol Scand       Date:  1981-10

9.  NXY-059 for the treatment of acute ischemic stroke.

Authors:  Ashfaq Shuaib; Kennedy R Lees; Patrick Lyden; James Grotta; Antonio Davalos; Stephen M Davis; Hans-Christoph Diener; Tim Ashwood; Warren W Wasiewski; Ugochi Emeribe
Journal:  N Engl J Med       Date:  2007-08-09       Impact factor: 91.245

10.  NXY-059: brain or vessel protection.

Authors:  Marc Fisher; Kennedy Lees; Michalis Papadakis; Alastair M Buchan
Journal:  Stroke       Date:  2006-06-29       Impact factor: 7.914

View more
  14 in total

1.  Safety and feasibility of NeuroFlo use in eight- to 24-hour ischemic stroke patients.

Authors:  M D Hammer; L Schwamm; S Starkman; P D Schellinger; T Jovin; R Nogueira; W S Burgin; S Sen; H C Diener; T Watson; P Michel; A Shuaib; W Dillon; D S Liebeskind
Journal:  Int J Stroke       Date:  2012-01-20       Impact factor: 5.266

2.  Partial aortic occlusion and cerebral venous steal: venous effects of arterial manipulation in acute stroke.

Authors:  Osvaldas Pranevicius; Mindaugas Pranevicius; David S Liebeskind
Journal:  Stroke       Date:  2011-03-24       Impact factor: 7.914

Review 3.  Ischemia-reperfusion injury in stroke.

Authors:  May Nour; Fabien Scalzo; David S Liebeskind
Journal:  Interv Neurol       Date:  2013-09

4.  Favorable vascular profile is an independent predictor of outcome: a post hoc analysis of the safety and efficacy of NeuroFlo Technology in Ischemic Stroke trial.

Authors:  Peter D Schellinger; Martin Köhrmann; Songling Liu; William P Dillon; Raul G Nogueira; Ashfaq Shuaib; David S Liebeskind
Journal:  Stroke       Date:  2013-04-02       Impact factor: 7.914

5.  Reduced mortality and severe disability rates in the SENTIS trial.

Authors:  P D Schellinger; A Shuaib; M Köhrmann; D S Liebeskind; T Jovin; M D Hammer; S Sen; D Y Huang; S Solander; R Gupta; R R Leker; J L Saver
Journal:  AJNR Am J Neuroradiol       Date:  2013-07-04       Impact factor: 3.825

6.  A novel treatment of distal cerebral vasospasm. A case report.

Authors:  I Alnaami; M Saqqur; M Chow
Journal:  Interv Neuroradiol       Date:  2009-12-28       Impact factor: 1.610

7.  Cerebral collateral circulation in carotid artery disease.

Authors:  José R Romero; Aleksandra Pikula; Thanh N Nguyen; Yih Lin Nien; Alexander Norbash; Viken L Babikian
Journal:  Curr Cardiol Rev       Date:  2009-11

8.  Effects of age on outcome in the SENTIS trial: better outcomes in elderly patients.

Authors:  Ronen R Leker; Carlos Molina; Kevin Cockroft; David S Liebeskind; Mauricio Concha; Ashfaq Shuaib; Peter Paul De Deyn; W Scott Burgin; Rishi Gupta; William Dillon; Hans-Christoph Diener
Journal:  Cerebrovasc Dis       Date:  2012-10-11       Impact factor: 2.762

9.  Venous hemodynamics may enhance collateral perfusion and the fibrinolytic milieu in paradoxical embolism.

Authors:  David S Liebeskind
Journal:  Stroke       Date:  2008-12-18       Impact factor: 7.914

Review 10.  How well do blood flow imaging and collaterals on angiography predict brain at risk?

Authors:  David S Liebeskind; Nerses Sanossian
Journal:  Neurology       Date:  2012-09-25       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.